Verica Aleksic Sabo
Overview
Explore the profile of Verica Aleksic Sabo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nikolic I, Aleksic Sabo V, Gavric D, Knezevic P
Antibiotics (Basel)
. 2024 Nov;
13(11).
PMID: 39596725
Background: MSSA and MRSA strains are challenging human pathogens that can develop resistance to antibiotics, highlighting the need for alternative antimicrobial agents. Plant metabolites, particularly volatile phytochemicals, may offer promising...
2.
Aleksic Sabo V, Skoric D, Jovanovic-Santa S, Knezevic P
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39335053
has been designated as a critical priority pathogen by the World Health Organization for the development of novel antimicrobial agents. This study aimed to investigate both the phenotypic and genotypic...
3.
Vukovic D, Gostimirovic S, Cvetanovic J, Gavric D, Aleksic Sabo V, Todorovic D, et al.
Curr Microbiol
. 2024 Jun;
81(7):215.
PMID: 38849666
Non-tailed icosahedral phages belonging to families Fiersviridae (phages MS2 and Qbeta), Tectiviridae (PRD1) and Microviridae (phiX174) have not been considered in detail so far as potential antibacterial agents. The aim...
4.
Nikolic I, Vukovic D, Gavric D, Cvetanovic J, Aleksic Sabo V, Gostimirovic S, et al.
Viruses
. 2022 Jul;
14(7).
PMID: 35891522
Phage-antibiotic synergy is a promising therapeutic strategy, but there is no reliable method for synergism estimation. Although the time-kill curve assay is a gold standard, the method is not appropriate...
5.
Petrovic Fabijan A, Aleksic Sabo V, Gavric D, Doffkay Z, Rakhely G, Knezevic P
Viruses
. 2021 Sep;
13(9).
PMID: 34578315
is a respiratory animal pathogen that shows growing resistance to commonly used antibiotics, which has necessitated the examination of new antimicrobials, including bacteriophages. In this study, we examined the previously...
6.
Wojtys M, Jazwiec R, Kazazic S, Asler I, Knezevic P, Aleksic Sabo V, et al.
Appl Microbiol Biotechnol
. 2021 Sep;
105(20):7949-7967.
PMID: 34562116
Due to the growing number of Helicobacter pylori strains resistant to currently available antibiotics, there is an urgent need to design new drugs utilizing different molecular mechanisms than those that...
7.
Aleksic Sabo V, Nikolic I, Mimica-Dukic N, Knezevic P
Nat Prod Res
. 2020 Aug;
35(24):5964-5967.
PMID: 32815402
is one of the emerging multidrug- and pandrug-resistant pathogens. The aim of the study was to determine anti- activity of selected terpenes, terpenoids and phenylpropanoids alone, in binary combinations, and...
8.
Aleksic Sabo V, Skoric D, Jovanovic-Santa S, Nikolic I, Janos C, Knezevic P
J Ethnopharmacol
. 2020 Aug;
264:113266.
PMID: 32810621
Ethnopharmacological Relevance: Bile traditionally was used in wound healing, having erodent, antioxidant and antimicrobial potential. Acinetobacter baumannii is a frequent etiological agent of wound infections, exhibiting high level of resistance...
9.
Aleksic Sabo V, Knezevic P
Ind Crops Prod
. 2020 Apr;
132:413-429.
PMID: 32288268
has become one of the world's most widely planted genera and (The River Red Gum) is a plantation species in many parts of the world. The plant traditional medical application...
10.
Knezevic P, Aleksic Sabo V, Simin N, Lesjak M, Mimica-Dukic N
J Pharm Biomed Anal
. 2018 Feb;
152:271-278.
PMID: 29448222
Helicobacter pylori is a major infective etiological agent of the upper gastrointestinal tract diseases. The bacterium exhibits resistance to various conventional antibiotics, being usually challenging for eradication. Since there is...